These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2201426)

  • 21. Nevi, other than dysplastic and Spitz nevi.
    Cochran AJ; Bailly C; Paul E; Dolbeau D
    Semin Diagn Pathol; 1993 Feb; 10(1):3-17. PubMed ID: 8506415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunohistochemical study of nevocellular nevi].
    Nakamura S
    Nihon Hifuka Gakkai Zasshi; 1989 May; 99(6):709-16. PubMed ID: 2685414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase.
    Burnier MN; McLean IW; Gamel JW
    Cancer; 1991 Aug; 68(4):809-14. PubMed ID: 1855181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical study of S-100 protein and neuron specific enolase (NSE) in melanocytes and the related tumors.
    Hachisuka H; Sakamoto F; Nomura H; Mori O; Sasai Y
    Acta Histochem; 1986; 80(2):215-23. PubMed ID: 3101377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody.
    Fernando SS; Johnson S; Bäte J
    Pathology; 1994 Jan; 26(1):16-9. PubMed ID: 8165017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A; McNutt NS
    Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of five antimelanoma antibodies for identification of melanocytic cells on tissue sections in routine dermatopathology.
    Thomson W; MacKie RM
    J Am Acad Dermatol; 1989 Dec; 21(6):1280-4. PubMed ID: 2685063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of S-100 immunostaining as a diagnostic tool in human malignant melanomas. A comparative study using S-100 and neuron-specific enolase antibodies.
    Springall DR; Gu J; Cocchia D; Michetti F; Levene A; Levene MM; Marangos PJ; Bloom SR; Polak JM
    Virchows Arch A Pathol Anat Histopathol; 1983; 400(3):331-43. PubMed ID: 6412442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of ras oncogene products among the types of human melanomas and melanocytic nevi.
    Yasuda H; Kobayashi H; Ohkawara A; Kuzumaki N
    J Invest Dermatol; 1989 Jul; 93(1):54-9. PubMed ID: 2664010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative immunoreactivity of CD-68 and HMB-45 in malignant melanoma, neural tumors and nevi.
    Shah IA; Gani OS; Wheler L
    Pathol Res Pract; 1997; 193(7):497-502. PubMed ID: 9342756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Actin-binding protein expression in benign and malignant melanocytic proliferations.
    Bouffard D; Duncan LM; Howard CA; Mihm MC; Byers HR
    Hum Pathol; 1994 Jul; 25(7):709-14. PubMed ID: 8026830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of human monoclonal antibody (2-139-1) in cutaneous melanocytic neoplasms in fixed tissue sections.
    White WL; Tam ST; Mitchell MS; Yu MC; Kan-Mitchell J
    J Histochem Cytochem; 1991 Jun; 39(6):777-85. PubMed ID: 1709658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibody (AFH1) immunoreactive on morphologically abnormal basal melanocytes within dysplastic nevi, nevocellular nevus nests, and melanoma.
    Aronson PJ; Ito K; Fukaya T; Hashimoto K; Mehregan AH
    J Invest Dermatol; 1988 Apr; 90(4):452-8. PubMed ID: 3280697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical localization of S-100 protein and its subunits in melanotic lesions in the oral mucosa and skin.
    Fujita S; Takahashi H; Tsuda N; Okabe H
    J Oral Pathol Med; 1991 Oct; 20(9):429-32. PubMed ID: 1804988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen and progesterone receptors in melanocytic lesions. Occurrence in patients with dysplastic nevus syndrome.
    Ellis DL; Wheeland RG; Solomon H
    Arch Dermatol; 1985 Oct; 121(10):1282-5. PubMed ID: 4037821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In situ distribution of integrin alpha 2 beta 1 and alpha-actinin in melanocytic proliferations.
    Duncan LM; Bouffard D; Howard C; Mihm MC; Byers HR
    Mod Pathol; 1996 Sep; 9(9):938-43. PubMed ID: 8878027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen and progesterone receptors in primary cutaneous melanoma.
    Ellis DL; Wheeland RG; Solomon H
    J Dermatol Surg Oncol; 1985 Jan; 11(1):54-9. PubMed ID: 3965520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
    Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
    Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SM5-1: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions.
    Trefzer U; Rietz N; Chen Y; Audring H; Herberth G; Siegel P; Reinke S; Königer P; Wu S; Ma J; Liu Y; Wang H; Sterry W; Guo Y
    Arch Dermatol Res; 2000 Dec; 292(12):583-9. PubMed ID: 11214818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.